Evgen Pharma (LON:EVG)

Evgen Pharma (LON:EVG)


Share Price
20.75 p
Change
0.35 (1.72 %)
Market Cap
£20.54 m
Proactive Investors - Run By Investors For Investors

Evgen Pharma

Evgen Pharma plc, a clinical stage drug development company focused on the treatment of cancer and neurological conditions.

EPIC: EVG
Market: AIM:EVG
52-week High/Low: 33.00p / 12.50p
Sector: Pharma & Biotech
Market Cap: £20.54 m
Website: evgen.com
col 3
col 4
col 5
col 6

Evgen Pharma Timeline

RNS
March 18 2019
RNS
February 06 2019
RNS
January 30 2019
RNS
January 22 2019
Newswire
December 12 2018
CN Video
March 07 2018

Columns Including EVG

VIEW ALL

Market Reports Including EVG

VIEW ALL
Video RSS

Videos

VIEW ALL VIDEOS

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use